IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 27, Issue 4, 2009, Pages 603-608

  Hermann, J ^a   Gruber, S ^c   Neufeld, J B ^c   Grundtner, P ^c   Graninger, M ^a   Graninger, W B ^a   Berghold, A ^b   Gasche, Christoph ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Division of Gastroenterology and Hepatology   (Austria)

Author keywords

IL10R1; Interleukin 10 receptor; Rheumatoid arthritis; Single nucleotide polymorphism; Systemic lupus erythematosus

Indexed keywords

CD150 ANTIGEN; DNA; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CLONING; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; CLONE CELLS; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; HELA CELLS; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION;

EID: 70350167868     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. MOORE KW, DE WAAL MR, COFFMAN RL, O'GARRA A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
2. PARK YB, LEE SK, KIM DS, LEE J, LEE CH, SONG CH: Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16: 283-288 (Pubitemid 28219167)
3. LLORENTE L, RICHAUD-PATIN Y: The role of interleukin-10 in systemic lupus erythematosus. J Autoimmun 2003; 20: 287-289 (Pubitemid 36677520)
4. ISHIDA H, MUCHAMUEL T, SAKAGUCHI S, ANDRADE S, MENON S, HOWARD M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994; 179: 305-10.
5. LLORENTE L, RICHAUD-PATIN Y, GARCIA-PADILLA C et al: Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 1790-1800
6. KATSIKIS PD, CHU CQ, BRENNAN FM, MAINI RN, FELDMANN M: Immuno-regulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-1527 (Pubitemid 24129569)
7. QUATTROCCHI E, DALLMAN MJ, DHILLON AP, QUAGLIA A, BAGNATO G, FELDMANN M: Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J Immunol 2001; 166: 5970-5978
8. TILG H, VAN MONTFRANS C, VAN DEN ENDE A et al.: Treatment of Crohn's disease with recombinant human interleukin 10 induces the pro-inflammatory cytokine interferon gamma. Gut 2002; 50: 191-195
9. VAN ROON J, WIJNGAARDEN S, LAFEBER FP, DAMEN C, VAN DE WINKEL J, BIJLSMA JW: Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation. J Rheumatol 2003; 30: 648-651
10. ESKDALE J, GALLAGHER G, VERWEIJ CL, KEIJSERS V, WESTENDORP RG, HUIZINGA TW: Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470
11. SCHOTTE H, SCHLUTER B, DRYNDA S et al.: Interleukin 10 promoter microsatellite polymorphisms are associated with response to long-term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 575-581
12. LAZARUS M, HAJEER AH, TURNER D et al.: Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314-2317 (Pubitemid 28005128)
13. CAIRNS AP, CROCKARD AD, BELL AL: Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 83-6.
14. BERLATO C, CASSATELLA MA, KINJYO I, GATTO L, YOSHIMURA A, BAZZONI F: Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 2002; 168: 6404-6411
15. JUNG M, SABAT R, KRATZSCHMAR J et al.: Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur J Immunol 2004; 34: 481-493
16. GASCHE C, GRUNDTNER P, ZWIRN P et al.: Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production. J Immunol 2003; 170: 5578-5582
17. GRUNDTNER P, GRUBER S, MURRAY SS et al.: The IL-10R1 S138G loss-of-function allele and ulcerative colitis. Genes Immun 2009; 10: 84-92.
18. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
19. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
20. HOFER H, NEUFELD JB, OESTERREICHER C et al.: Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun 2005; 6: 242-247
21. NAKASHIMA H, AKAHOSHI M, TANAKA Y et al.: Polymorphisms within the interleukin-10 receptor cDNA gene (IL10R) in Japanese patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38: 1142-1144